What is NDC 55150-388?

55150-388 is the product NDC for Posaconazole, Posaconazole 18 mg/mL injection, listed with the FDA by Eugia US LLC. It has 1 package NDC, shown above in 10- and 11-digit form.

Eugia US LLC, NDC labeler code 55150. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Posaconazole?

32 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Posaconazole NDC 55150-388 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)55150-388Labeler and product segments. Claims need a package NDC.

Product NDC at billing width55150-0388Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
55150-388-01	5515003880155150038801	1 VIAL, SINGLE-DOSE in 1 CARTON (55150-388-01) / 16.7 mL in 1 VIAL, SINGLE-DOSEMarketed from Dec 26, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Posaconazole
Generic name (nonproprietary): posaconazole
Active ingredients: Posaconazole — 18 mg/mL
Dosage form: Injection
Route: Intravenous
Labeler: Eugia US LLCNDC labeler code 55150
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 214842
Marketing start: Dec 26, 2023
Listing expires: Dec 31, 2026
Other FDA classes: Azoles (Chemical structure)
Identifiers: Product ID 55150-388_6d1e5905-71b9-480b-82ae-5c92a2374e1dSPL ID 6d1e5905-71b9-480b-82ae-5c92a2374e1dSPL set ID 2e88e379-b712-4dec-97a2-c90ef3638372RxCUI 1492043UNII 6TK1G07BHZUPC 0355150388011
Pharmacologic class: Azole Antifungal

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N455150038801 followed by a unit qualifier and the quantity

Package 55150-0388-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 7, 2025.

Indications (excerpt from the label)

Posaconazole injection is an azole antifungal indicated as follows: Posaconazole injection is indicated for the treatment of invasive aspergillosis in adults and pediatric patients 13 years of age and older. (1.1) Posaconazole injection is indicated for the prophylaxis of invasive Aspergillus and Candida infections in patients who are at high risk of developing these infections due to being severely immunocompromised, such as hematopoietic stem cell transplant (HSCT) recipients with graft-versus-host disease (GVHD) or those with hematologic malignancies with prolonged neutropenia from chemotherapy as follows: ( 1.2 ) o Posaconazole injection: adults and pediatric patients 2 years of age and …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 55150-388

What is NDC 55150-388?: 55150-388 is the product NDC for Posaconazole, Posaconazole 18 mg/mL injection, listed with the FDA by Eugia US LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Posaconazole.
What is the active ingredient?: Posaconazole.
Who is the labeler?: Eugia US LLC, NDC labeler code 55150. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Posaconazole?: 32 other product NDCs are listed under this name. See all Posaconazole NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Posaconazole NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
posaconazole	Posaconazole 100 mg/1	Tablet, CoatedOral	Novadoz Pharmaceuticals LLC	72205-168	72205-0168-60
Posaconazole	Posaconazole 18 mg/mL	SolutionIntravenous	Camber Pharmaceuticals, Inc.	31722-370	31722-0370-31
Posaconazole	Posaconazole 100 mg/1	Tablet, Delayed releaseOral	Aurobindo Pharma Limited	59651-596	59651-0596-60
posaconazole	Posaconazole 18 mg/mL	Injection, SolutionIntravenous	GLENMARK PHARMACEUTICALS INC., USA	68462-911	68462-0911-01
Posaconazole	Posaconazole 100 mg/1	Tablet, Delayed releaseOral	A2A Integrated Pharmaceuticals	73141-023	73141-0023-02
posaconazole	Posaconazole 18 mg/mL	SolutionIntravenous	Mylan Institutional LLC	67457-665	67457-0665-20
posaconazole	Posaconazole 18 mg/mL	Injection, SolutionIntravenous	GLENMARK PHARMACEUTICALS INC., USA	68462-904	68462-0904-01
Posaconazole	Posaconazole 18 mg/mL	Injection, SolutionIntravenous	Fresensius Kabi USA, LLC	63323-685	63323-0685-17
posaconazole	Posaconazole 18 mg/mL	Injection, SolutionIntravenous	Gland Pharma Limited	68083-577	68083-0577-01
Posaconazole	Posaconazole 100 mg/1	Tablet, Delayed releaseOral	Bryant Ranch Prepack	71335-2665	71335-2665-01

All 33 Posaconazole NDCs